Manufacture, marketing and supply

Part of Medicines and Medical Devices Bill – in a Public Bill Committee am 12:30 pm ar 8 Mehefin 2020.

Danfonwch hysbysiad imi am ddadleuon fel hyn

New clause 4—Antimicrobial Resistance—

‘(1) The Secretary of State must regard antimicrobial resistance a priority in the development of new medicines.

(2) The Secretary of State must, within 12 months of this Act receiving Royal Assent, lay an updated report before Parliament setting out a UK-wide strategy for tackling antimicrobial resistance.’.

This new clause requires the Government to prioritise tackling antimicrobial resistance and produce an updated report setting out how it shall do so.